# Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)

> **NCT02195323** · PHASE1 · COMPLETED · sponsor: **Royan Institute** · enrollment: 7 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **BIOLOGICAL:** Intravenous injection

## Key facts

- **NCT ID:** NCT02195323
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2016-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195323, "Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02195323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*